Evidence map›Paper›PMID 39526049›Full record

SynthesisTouchREVIEWS in endocrinology2024

Role of Obeticholic Acid, a Farnesoid X Receptor Agonist, in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.

Abm Kamrul-Hasan, Sunetra Mondal, Lakshmi Nagendra, Thanikai Sasikanth, Afsar Ahammed, Shahin Ibn Rahman, Ashani Wickramarachchi, Naresh Parajuli, Saurav Khatiwada, Deep Dutta

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in TouchREVIEWS in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07104786 (Effectiveness of Obeticholic Acid Versus Vitamin E in Patients of Non-alcoholic Fatty Liver Disease), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07104786 phase2completednot on this map

Effectiveness of Obeticholic Acid Versus Vitamin E in Patients of Non-alcoholic Fatty Liver Disease

TypeinterventionalSponsorKing Edward Medical UniversityRan2023 to 2024Enrolled90ConditionsNon Alcoholic Fatty Liver DiseaseArmsObeticholic Acid 10 MG, Vitamin E 400mg
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abm Kamrul-HasanDepartment of Endocrinology, Mymensingh Medical College, Mymensingh, Bangladesh.
Sunetra MondalDepartment of Endocrinology, NRS Medical College, Kolkata, India.
Lakshmi NagendraDepartment of Endocrinology, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India.
Thanikai SasikanthDepartment of Endocrinology, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Afsar AhammedDepartment of Endocrinology, National Institute of Traumatology & Orthopaedic Rehabilitation, Dhaka, Bangladesh.
Shahin Ibn RahmanDepartment of Endocrinology, BIRDEM General Hospital, Shahbag, Dhaka, Bangladesh.
Ashani WickramarachchiDepartment of Endocrinology, University Medical Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Naresh ParajuliDepartment of Medicine, Endocrine Unit, Tribhuvan University Institute of Medicine, Kathmandu, Nepal.
Saurav KhatiwadaDepartment of Medicine, Endocrine Unit, Chitwan Medical College, Bharatpur, Chitwan, Nepal.
Deep DuttaDepartment of Endocrinology, CEDAR Superspeciality Healthcare, Dwarka, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Farnesoid X nuclear receptorhepatic transaminasesmeta-analysismetabolic dysfunction-associated fatty liver diseasenonalcoholic fatty liver diseasenonalcoholic steatohepatitisobeticholic acid

Identifiers

PMID39526049
PMCPMC11548348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.